Most tumors are composed of a heterogeneous population of subclones. A more detailed insight into the subclonal evolution of these tumors can be helpful to study progression and treatment response. Problematically, tumor samples are typically very heterogeneous, making deconvolving individual tumor subclones a major challenge. To overcome this limitation, reducing heterogeneity, such as by means of microdissections, coupled with targeted sequencing, is a viable approach. However, computational methods that enable reconstruction of the evolutionary relationships require unbiased read depth measurements, which are commonly challenging to obtain in this setting. We introduce TargetClone, a novel method to reconstruct the subclonal evolution tr...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...
Understanding the clonal architecture and evolutionary history of a tumour poses one of the key chal...
Abstract The vast majority of cancer next-generation sequencing data consist of bulk samples compose...
Most tumors are composed of a heterogeneous population of subclones. A more detailed insight into th...
Most tumors are composed of a heterogeneous population of subclones. A more detailed insight into th...
(A) Expected development of TGCC based on knowledge described in literature. (B) Tree reconstructed ...
Methods for reconstructing tumor evolution are benchmarked in the DREAM Somatic Mutation Calling Tum...
The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, wi...
Cancer is a genetic disease characterized by the emergence of genetically distinct populations of ce...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
(A) Example of the true T for 6 hypothetical subclones. (B) Distance matrices reconstructed from the...
Tumours are composed of multiple subpopulations, each of which has its own genotype and phenotype. ...
(A) Mean of the error rates and 95% confidence intervals as a function of different tumor fractions ...
Clonal deconvolution of mutational landscapes is crucial to understand the evolutionary dynamics of ...
The extensive genetic heterogeneity of cancers can greatly affect therapy success due to the existen...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...
Understanding the clonal architecture and evolutionary history of a tumour poses one of the key chal...
Abstract The vast majority of cancer next-generation sequencing data consist of bulk samples compose...
Most tumors are composed of a heterogeneous population of subclones. A more detailed insight into th...
Most tumors are composed of a heterogeneous population of subclones. A more detailed insight into th...
(A) Expected development of TGCC based on knowledge described in literature. (B) Tree reconstructed ...
Methods for reconstructing tumor evolution are benchmarked in the DREAM Somatic Mutation Calling Tum...
The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, wi...
Cancer is a genetic disease characterized by the emergence of genetically distinct populations of ce...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
(A) Example of the true T for 6 hypothetical subclones. (B) Distance matrices reconstructed from the...
Tumours are composed of multiple subpopulations, each of which has its own genotype and phenotype. ...
(A) Mean of the error rates and 95% confidence intervals as a function of different tumor fractions ...
Clonal deconvolution of mutational landscapes is crucial to understand the evolutionary dynamics of ...
The extensive genetic heterogeneity of cancers can greatly affect therapy success due to the existen...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...
Understanding the clonal architecture and evolutionary history of a tumour poses one of the key chal...
Abstract The vast majority of cancer next-generation sequencing data consist of bulk samples compose...